Market Research Logo

Global Insomnia Market - Market Research Analysis 2015-2019

About insomnia

Insomnia or sleeplessness is characterized by the difficulty in falling asleep or remaining asleep, resulting in poor quality of sleep or little sleep. Sleeplessness can be acute or chronic. Work-related stress is the more common factor for acute or primary insomnia, while medical conditions, such as arthritis, or medicines, such as amphetamines, and substances, such as cocaine, are the common factors for chronic insomnia.

Technavio's analysts forecast the global insomnia market to decline at a CAGR of 3.08% over the period 2014-2019.



Covered in this report

The report includes the present scenario and the growth prospects of the global insomnia market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of insomnia.

Technavio's report, Global Insomnia Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.Key regions

  • Americas
  • APAC
  • EMEA
Key vendors
  • Eisai
  • Merck
  • Pfizer
  • Sanofi
  • Takeda
Other prominent vendors
  • Astellas
  • Biocodex
  • Dainippon Sumitomo
  • ECR Pharmaceuticals (Valeant)
  • Fidia Farmaceutici
  • Flynn Pharma
  • Johnson & Johnson
  • Juste
  • Meda
Key market driver
  • Unmet medical needs
  • For a full, detailed list, view our report
Key market challenge
  • Dominance of generic products
  • For a full, detailed list, view our report
Key market trend
  • Emerging drugs targeting orexin receptors
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Insomnia: An overview
    • Introduction
    • Epidemiology
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global insomnia drugs market 2014-2019 ($ billions)
      • Table Key performance indicators of global insomnia drugs market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline portfolio
    • Table Pipeline portfolio
    • Examples of pipeline candidates
  • Market segmentation by type of formulation
    • Table Market segmentation by type of formulation
    • Tablets
    • Capsules
    • Mist formulation
  • Market segmentation by symptom
    • Market overview
      • Table Market segmentation by symptom
    • Poor-quality sleep
    • Difficulties with sleep onset and/or maintenance
    • Others
  • Geographical segmentation
    • Market overview
      • Table Geographical segmentation 2014
  • Market drivers
    • Table Global insomnia drugs market: Key drivers
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Table Global insomnia drugs market: Key challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Global insomnia drugs market: Emerging trends
  • Vendor landscape
    • Competitive scenario
    • Market share analysis
      • Table Lunesta sales in North America 2011-2014 ($ millions)
      • Table Lunesta sales in Japan 2013-2014 ($ millions)
      • Table Ambien: Global sales 2011-2014 ($ millions)
      • Table Ambien sales in Western Europe 2011-2014 ($ millions)
      • Table Ambien sales in the US 2011-2014 ($ millions)
      • Table Ambien sales in emerging markets 2011-2014 ($ millions)
      • Table Ambien sales in ROW 2011-2014 ($ millions)
      • Table Rozerem: Global sales 2011-2013 ($ millions)
      • Table Rozerem sales in Japan 2012-2014 ($ millions)
    • Other prominent vendors
  • Key vendor analysis
    • Eisai
    • Merck
    • Pfizer
    • Sanofi
    • Takeda
      • Table Takeda: Business segmentation by revenue 2015
      • Table Takeda: Business segmentation by revenue 2014 and 2015 ($ millions)
      • Table Takeda: Geographical segmentation by revenue 2015
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report